Print
Email
Cubist Pharmaceuticals Inc. has a market cap of $2.47 billion; its shares were traded at around $40.05 with a P/E ratio of 24.9 and P/S ratio of 3.9.
This is the insider trade history vs. stock price of CBST. For the complete insider trading history of CBST, click here.
Directors and Officers Recent Trades:
- Director Leon O Jr Moulder bought 5,000 shares of CBST stock on 11/04/2011 at the average price of 36.78. Leon O Jr Moulder owns at least 5,883 shares after this. The price of the stock has increased by 8.89% since.
- Director Nancy J Hutson bought 1,500 shares of CBST stock on 10/26/2011 at the average price of 38.66. Nancy J Hutson owns at least 3,500 shares after this. The price of the stock has increased by 3.6% since.
- Director Martin Rosenberg sold 11,500 shares of CBST stock on 12/15/2011 at the average price of 37.1. Martin Rosenberg owns at least 4,658 shares after this. The price of the stock has increased by 7.95% since.
- SVP & Chief Medical Officer Santosh Vetticaden sold 55,000 shares of CBST stock on 10/26/2011 at the average price of 38.6. Santosh Vetticaden owns at least 8,433 shares after this. The price of the stock has increased by 3.76% since.
- SVP, Commercial Operations Gregory Stea sold 50,938 shares of CBST stock on 10/26/2011 at the average price of 38.49. Gregory Stea owns at least 8,817 shares after this. The price of the stock has increased by 4.05% since.
For the complete insider trading history of CBST, click here.
Subscribe RSS
